October 16, 2018
Researchers from the Abramson Cancer Center found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone—and patients responded favorably to targeted therapies. The findings, published in in JAMA Oncology, show that the addition of liquid biopsy nearly doubled the number of mutations detected compared to what […]
